Molecular studies on the action of APOBEC3G against HIV-1 and development of an APOBEC-based anti-HIV approach
Currently, the HIV pandemic remains a major global health challenge. In order to effectively control and cure HIV-1 infection, it is necessary to perform greater research on host-HIV interactions and develop novel preventive and therapeutic approaches. The human cytidine deaminase APOBEC3G (A3G) is...
Main Author: | Wang, Xiaoxia |
---|---|
Other Authors: | Yao, Xiao-Jian (Medical Microbiology) |
Published: |
American Society for Microbiology
2014
|
Subjects: | |
Online Access: | http://hdl.handle.net/1993/23226 |
Similar Items
-
APOBEC3G and APOBEC3F rarely co-mutate the same HIV genome
by: Ebrahimi Diako, et al.
Published: (2012-12-01) -
Proviral HIV-1 hypermutation: the correlation of APOBEC3G/F and HIV-1 Vif in HIV-1 disease progression
by: De, Sujata Monika
Published: (2011) -
Proviral HIV-1 hypermutation: the correlation of APOBEC3G/F and HIV-1 Vif in HIV-1 disease progression
by: De, Sujata Monika
Published: (2011) -
Biochemical analysis of HIV restriction factors : Single domain deoxycytidine deaminases APOBEC3A and APOBEC3H
Published: (2014) -
Degradation-Independent Inhibition of APOBEC3G by the HIV-1 Vif Protein
by: Benjamin Stupfler, et al.
Published: (2021-04-01)